LRP6 and neoplasm: Additionally, cell-cell communication analysis revealed that in chemotherapy-resistant patients, STAR + cells interact with tumor cells through Wnt signaling, specifically via ligand-receptor pairs such as WNT7A-FZD6/FZD3-LRP6/LRP5, components of the canonical Wnt pathway.